Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Effect of histamine on the expression of metalloproteinases and cell adhesion in breast cancer cell lines

    F. Genre, E. Valli, V. Medina, A. Gutiérrez, L. Sambuco, E. Rivera in Inflammation Research (2009)

  2. No Access

    Article

    Nitric oxide involvement in histamine-mediated PANC-1 cells growth

    G. Cricco, V. Medina, M. Núñez, N. Mohamad, A. Gutiérrez in Inflammation Research (2007)

  3. No Access

    Article

    Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

    Purpose: To evaluate the feasibility, toxicity and efficacy of the combination of docetaxel and mitomycin C as second-line chemotherapy in patients with advanced non-small cell lung cance...

    J. Feliu, G. Martín, J. Castro, A. Sundlov in Cancer Chemotherapy and Pharmacology (2006)

  4. No Access

    Article

    Histamine modulates cellular events involved in tumour invasiveness in pancreatic carcinoma cells

    .

    G. Cricco, M. Núñez, V. Medina, G. Garbarino, N. Mohamad in Inflammation Research (2006)

  5. No Access

    Article

    Histamine is a selective protector against cellular damage produced by ionizing radiation

    .

    V. Medina, G. Cricco, N. Mohamad, M. Croci, M. Núñez, G. Martín in Inflammation Research (2005)

  6. No Access

    Article

    Histamine regulates the MAPK pathway via the H2 receptor in PANC-1 human cells

    G. Cricco, G. Martín, V. Medina, M. Núñez, A. Gutiérrez, C. Cocca in Inflammation Research (2004)

  7. No Access

    Article

    Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

    To evaluate the feasibility, toxicity and efficacy of the combination of low-dose cisplatin (CDDP) and gemcitabine (GEM) in elderly patients with advanced non-small-cell lung cancer (NSCLC).

    J. Feliu, G. Martín, C. Madroñal in Cancer Chemotherapy and Pharmacology (2003)

  8. No Access

    Article

    Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes

    Objectives: To determine the regulatory effects of reactive oxygen species (ROS) on the expression by human osteoarthritic chondrocytes of interleukin (IL)-1β, -6 and -8, inducible nitric oxide synthase (iNOS) a...

    M. Mathy-Hartert, G. Martin, P. Devel, G. Deby-Dupont, J.-P. Pujol in Inflammation Research (2003)

  9. No Access

    Article

    Histamine inhibits proliferation of a pancreatic carcinoma cell line without inducing apoptosis significantly

    G. Martín, G. Cricco, Z. Darvas, M. Croci, M. Núñez, R. Bergoc in Inflammation Research (2002)

  10. No Access

    Article

    Histamine production in mouse epidermal keratinocytes is regulated during cellular differentiation

    C. Fitzsimons, N. Engel, H. Durán, L. Policastro, G. Cricco in Inflammation Research (2001)

  11. No Access

    Article

    Histamine as a potential autocrine regulator of melanoma

    E. L. Molnar, G. Cricco, G. Martin, Z. Darvas, H. Hegyesi in Inflammation Research (2001)

  12. No Access

    Article

    Human pancreatic carcinoma cell line Panc-I and the role of histamine in growth regulation

    G. Cricco, G. Martin, F. Labombarda, C. Cocca, R. Bergoc in Inflammation Research (2000)

  13. No Access

    Article

    Fluoromethylhistidine inhibits tumor growth without producing depletion of endogenous histamine

    G. Cricco, N. Engel, M. Croci, C. Davio, G. Martín, C. Fitzsimons in Inflammation Research (1997)

  14. No Access

    Article

    Advantages and limitations of the use of isolated kidney tubules in pharmacotoxicology

    Among the cellular models used in in vitro renal pharmacotoxicology, isolated kidney tubules, used as suspensions mainly of proximal tubules, offer important advantages. They can be prepared in large amounts unde...

    M. F. Chauvin, C. Bolon, A. Conjard, G. Martin, B. Ferrier in Cell Biology and Toxicology (1996)

  15. No Access

    Article

    Histamine regulates the expression of histidine decarboxylase in N-nitroso-N-methylurea (NMU)-induced mammary tumors in rats

    N. Engel, G. Cricco, C. Davio, G. Martin, M. Croci, C. Fitzsimons in Inflammation Research (1996)

  16. No Access

    Article

    Histamine receptors in human mammary gland, different benign lesions and mammary carcinomas

    B. Lemos, C. Davio, H. Gass, P. Gonzalez, G. Cricco, G. Martin in Inflammation Research (1995)

  17. No Access

    Article

    Histamine as an autocrine growth factor in experimental mammary carcinomas

    In order to determine the role of endogenous histamine in the regulation of cell growth, thein vitro action of fluoromethyl-histidine (MFMH) was studied in experimental mammary carcinomas induced in rats. Tumor c...

    G. P. Cricco, C. A. Davio, G. Martin, N. Engel, C. P. Fitzsimons in Agents and Actions (1994)

  18. No Access

    Article

    Effect of histamine on growth and differentiation of the rat mammary gland

    The presence of H1 and H2 histamine receptors and their associated second messenger systems were studied during the development of the rat mammary gland. In the tissue of the young female, histamine presented ...

    C. A. Davio, G. P. Cricco, G. Martin, C. P. Fitzsimons, R. M. Bergoc in Agents and Actions (1994)

  19. No Access

    Chapter and Conference Paper

    A combination chemotherapy with Ifosfamide (I), Cisplatin (P) and Etoposide (E) for advanced non-small cell lung cancer (NSCLC)

    The role of combination chemotherapy in the treatment of NSCLC remains controversial. One of the most widely used conbinations is PE which yielded a 32 % response rate in 682 patients [1]. Efforts to improve t...

    G. Martin, M. J. Garcia, J. J. Cruz, A. Gómez, A. Panadero in Cancer Treatment An Update (1994)

  20. No Access

    Chapter and Conference Paper

    Induction chemotherapy with Cisplatin (P), 5-Fluorouracil (FU) and Folinic Acid (FA) in locally advanced head and neck cancer

    It has been observed that a synergism exists between Cisplatin (P) and 5-Fluorouracil (FU) when these agents are jointly administered in continuous perfusion.

    E. Fonseca, J. J. Cruz, J. Garcia, A. Panadero, P. Sanchez in Cancer Treatment An Update (1994)

previous disabled Page of 2